Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cristina Bozzao
Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors
PLoS ONE
Multidisciplinary
Impact of Cystic Fibrosis Transmembrane Regulator (CFTR) Gene Mutations on Male Infertility
Archivio Italiano di Urologia Andrologia
Urology
Related publications
In Vitro Efficacy of ARQ 092, an Allosteric AKT Inhibitor, on Primary Fibroblast Cells Derived From Patients With PIK3CA-related Overgrowth Spectrum (PROS)
Neurogenetics
Molecular Neuroscience
Genetics
Cellular
One of the First Cases With PIK3CA-related Overgrowth Spectrum (PROS) in Saudi Arabia: A Case Report and Literature Review
Cureus
Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
Clinical Cancer Research
Cancer Research
Oncology
Effect of PI3K/Akt/mTOR Signaling Pathway on JNK3 in Parkinsonian Rats
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates
Cancer Research
Cancer Research
Oncology
Erratum To: PI3K/Akt/mTOR Signaling in Medullary Thyroid Cancer: A Promising Molecular Target for Cancer Therapy
Endocrine
Activation of WNT/β-catenin Signaling Results in Resistance to a Dual PI3K/mTOR Inhibitor in Colorectal Cancer Cells Harboring PIK3CA Mutations
International Journal of Cancer
Cancer Research
Oncology
mTORC1 Inhibition Is Required for Sensitivity to PI3K P110 Inhibitors in PIK3CA-Mutant Breast Cancer
Science Translational Medicine
Medicine
